Page 2890 - Cote clinical veterinary advisor dogs and cats 4th

Boldface page numbers indicate chapter titles. Page numbers followed by a indicate algorithms; b, boxes; e, electronic content; f, figures; and t, tables. 1537

HSA. See Hemangiosarcoma Hyperadrenocorticism (Continued) Hypertension
5-HTP (5-Hydroxytryptophan, serotonin), 463t–464t mitotane induction hyperadrenocorticism and, 485
for adrenal tumor, 1425.e1a
idiopathic, 501
Hu G-CSF. See Filgrastim
VetBooks.ir Human chorionic gonadotropin (hCG) mitotane maintenance intra-abdominal, 2.e1
for pituitary disease, 1426a
in phenylpropanolamine toxicosis, 784
administration and dosage of, 1466
portal, cirrhotic/fibrosing liver disease and, 174
for follicular cysts, 822
for adrenal tumor, 1426.e1a
for pituitary disease, 1426.e2a
systemic. See Systemic hypertension
stimulation test, 225.e2
Human intravenous immunoglobulin. See occult, 490–491 Hyperthermia, 421–422, 1424a
Immunoglobulin paraneoplastic syndromes and, 754–756 heat stroke, 421–422, 1424a
Human monocytic ehrlichiosis, 285 in perianal and tail gland hyperplasia, 771.e2–771.e3 nonfebrile, 1238
Human monocytotropic ehrlichiosis, 285 polyuria/polydipsia and, 813 peritoneal dialysis and, 1151.e2
Humoral fracture, 358f, 361–362 suspect (conflicting results), 487–488 soft–tissue sarcoma and, 928
Humoral hypercalcemia of malignancy, 1371 trilostane therapy for, 1427a Hyperthyroidism, 503–505
Humulin. See Insulin Hyperaldosteronism, 491.e2–491.e3, 1304 polyuria/polydipsia and, 813
Humulin-R, 1510.e5 Hyperammonemic encephalopathy, 183 treatment of, 1238.e2, 1428.e1a
Humulus lupulus, 480 Hyperbilirubinemia, 1313, 1386 Hypertonic saline
Hungarian Vizsla. See Vizsla bile duct obstruction and, 118 for head trauma, 405
Hunter disease, 945.e2–945.e3 conjugated vs. unconjugated, 119 for syndrome of inappropriate antidiuretic hormone
Hunting dogs Hypercalcemia, 491–492, 754, 1320–1321 secretion, 955.e2
caudal myopathy in, 149.e2 anal sac adenocarcinoma and, 29 Hypertriglyceridemia, 1236
grass awn migration in, 398 causes of, 1232–1233 causes of, 1388–1389
histoplasmosis in, 476 cholecalciferol toxicosis and, 164–165 hyperlipidemia and, 497
infraspinatus tendon disorders in, 547–548 idiopathic feline, 492–493 lipemia and, 496–498
schistosomiasis in, 901.e2 peritoneal dialysis and, 1151.e2 treatment of, 497
Hurler syndrome, 945.e2–945.e3 thymoma and, 973–974 Hypertrophic cardiomyopathy (HCM), 505–507
Hustead needle, 1100.e2 Hypercalcemia of malignancy, 307, 606, 1263 congestive heart failure and, 408
Hyalohyphomycosis, 372–373 Hypercapnia, 1233 Hypertrophic obstructive cardiomyopathy (HOCM), 505
Hyaluronan, for osteochondrosis, 724 Hyperchloremia, 1234, 1323 Hypertrophic osteodystrophy (HOD), 507–508, 508f,
Hyaluronic acid, for keratoconjunctivitis sicca, Hyperchloremic metabolic acidosis, 15.e3, 879.e2 754, 1264
569 Hypercholesterolemia, 1234, 1324 Hypertrophic osteopathy, 508–509, 509f
Hycodan. See Hydrocodone hyperlipidemia and, 497–498 as paraneoplastic syndrome, 754–756
Hydatid cyst disease, 281.e1 in nephrotic syndrome, 691 spirocercosis and, 934
Hydatidosis, 281.e1 treatment of, 497 Hypertrophic pulmonary osteoarthropathy, 508–509
Hydralazine Hypercoagulable states, thromboembolism and, 75 Hypertrophic pulmonary osteopathy, 508–509
administration and dosage of, 1482 Hypercortisolemia, 485 Hypertrophic pyloric gastropathy, 851.e2
for hypertension, 784 Hyperemia, 494–495, 495.e1f, 1234 Hyperventilation. See also Panting
Hydrea. See Hydroxyurea conjunctival, episcleral/scleral, or palpebral. See Red eye for head trauma, 406
Hydrocephalus, 481–483, 483.e1f Hyperesthesia syndrome, feline, 589.e2 Hyperviscosity syndrome, 509–511, 754
Hydrochlorothiazide Hyperestrogenism multiple myeloma/plasma cell tumor and, 663
administration and dosage of, 1482 alopecia and, 1196 as paraneoplastic syndrome, 754–756
for chronic heart failure, 411 canine, 495.e2–495.e3 Hypervolemia, 1382–1383
for diabetes insipidus, 251 description of, 962 Hyphema, 511–512
Hydrocodone Hyperglobulinemia, 510, 1235 Hypoadrenocorticism, 512–515, 514.e1f
for acral lick dermatitis, 17 Hyperglycemia, 253.e3, 1235 collapse and, 193
administration and dosage of, 1482 Hypericin, in herbal remedies, 463t–464t diagnostic algorithm for, 1429a
for bordetellosis, 126 Hyperimmune serum, for tick paralysis, 977 myasthenia gravis and, 669
for collapsing trachea, 195 Hyperkalemia, 495–496, 496f polyuria/polydipsia and, 813
as cough suppressant, 218 artifactual, 101 Hypoalbuminemia
Hydrocortisone, 1510.e7t atrial, and atrial standstill, 8 causes of, 1239
Hydrocortisone acetate 1% cream, 1482 causes of, 1235–1236, 1374–1375 glomerulonephritis and, 390
HydroDIURIL. See Hydrochlorothiazide peritoneal dialysis and, 1151.e2 in nephrotic syndrome, 691
Hydrogen peroxide Hyperkalemic periodic paralysis, 1236 Hypocalcemia, 515–516, 1320–1321
administration and dosage of, 1482 Hyperkeratosis associated conditions, 1239
as emetic, 1188–1189 footpad, 215–216, 271 eclampsia and, 281
Hydromorphine, for bite-related pain, 120.e3 nasal, 215–216, 677f hyperphosphatemia and, 520
Hydromorphone, 1100.e2 Hyperkinetic pulse, 846 hypertrophic osteodystrophy and, 508
administration and dosage of, 1482 Hyperlactatemia, 1249.e2 hypoparathyroidism and, 519–520
for hit by car, 479 Hyperlipidemia, 496–498, 1236, 1324, 1360, 1388 panting and, 751
for neck pain, 683–684 Hyperlipoproteinemia. See Hyperlipidemia refractory, due to concurrent hypomagnesemia, 1364
for pain management, 931 Hypermagnesemia, 1364 Hypocapnia, 1239.e1
Hydronephrosis, 483–484, 1155.e2f Hypernatremia, 498–499 Hypochloremia, 1239.e1, 1323
renomegaly and, 879.e4 causes of, 1237 Hypochlorites, 1217.e1
Hydrophobia. See Rabies correction of, 1428a Hypocortisolism. See Hypoadrenocorticism
Hydroprene, 551.e2t osmotic. See Salt toxicosis Hypofibrinogenemia, 431t
Hydrothorax, 791–793 salt toxicosis and, 900.e2 Hypofractionated radiation, 927
5-Hydroxytryptophan (5-HTP, serotonin), 463t–464t Hyperosmolality, 1382 Hypogalactia, 570
Hydroxyurea Hyperosmolar hyperglycemic state (HSS), 253.e2–253.e3 Hypoglossal nerve deficits, 1210
administration and dosage of, 1482 Hyperosmolar nonketotic diabetes, 253.e2 Hypoglycemia, 1348
for chronic leukemia, 589 Hyperparathyroidism causes of, 1240, 1348
for Eisenmenger’s syndrome, 288.e2–288.e3 nutritional secondary, 697–698 extrapancreatic, 1264
for patent ductus arteriosus, type 4, 766 primary, 499–501 glycated hemoglobin and, 1349
for polycythemia, 511 renal secondary, 878–879 hepatic neoplasia and, 447
for polycythemia vera, 807 Hyperphosphatemia insulinoma and, 552
for tetralogy of Fallot, 966 acute tumor lysis syndrome and, 28.e2 paraneoplastic syndromes and, 754–756
Hydroxyzine causes of, 1237 soft–tissue sarcoma and, 927
administration and dosage of, 1482 cholecalciferol toxicosis and, 164–165 xylitol toxicosis and, 1050–1051
for atopic dermatitis, 93 vitamin D 3 analog toxicosis and, 164 Hypokalemia, 516–517
Hygroma, elbow, 290 Hyperpigmentation, 195–197 albuterol toxicosis as cause of, 43
Hyperadrenocorticism, 31, 485–487, 486.e1f Hyperplastic nodules, 449 causes of, 1240, 1374–1375
abdominal distention caused by, 2.e3 Hyperpnea. See Panting hyperaldosteronism and, 491.e2
adrenocortical neoplasia caused by, 35 Hyperproteinemia, 1237, 1387 polyuria/polydipsia and, 813
alopecia and, 1196 Hypersalivation. See Ptyalism refeeding syndrome and, 871.e2
atypical, 490 Hypersensitivity, 204.e2, 1238, 1311. See also refractory, concurrent hypomagnesemia as cause of,
calcinosis cutis and, 140.e4–140.e6, 140.e6f Anaphylaxis 1364
food-related/food-dependent, 489–490 Hypersomatotropism. See Acromegaly treatment of, 253.e3
www.ExpertConsult.com